Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma
- Status
- COMPLETED
- Phase
- N/A
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery
- Status
- RECRUITING
- Phase
- NA
A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
LAG3 Expression in Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)
- Status
- RECRUITING
- Phase
- NA
Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study of Cadonilimab (AK104) Plus Eribulin vs. Eribulin Monotherapy for Recurrent or Metastatic Triple-negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2